首页 | 本学科首页   官方微博 | 高级检索  
     

乳腺癌靶向治疗的分子基础
引用本文:李静,黄睿,刘秀娟,罗瑛,杨举伦. 乳腺癌靶向治疗的分子基础[J]. 生命的化学, 2014, 0(2): 306-311
作者姓名:李静  黄睿  刘秀娟  罗瑛  杨举伦
作者单位:[1]昆明理工大学医学院,昆明650500 [2]成都军区昆明总医院病理科,昆明650032 [3]昆明医科大学成都军区昆明总医院临床学院,昆明650031
基金项目:国家自然科学基金项目(30872994)
摘    要:近年来,乳腺癌靶向治疗的研究取得了显著进展。分子靶向药物通过作用于乳腺癌细胞相关细胞的分子信号传导途径,特异性针对异常环节进行干预,控制细胞基因的表达,从而抑制或杀死肿瘤细胞,以此达到治疗乳腺癌的目的。本文将对乳腺癌靶向治疗的分子基础研究进展做一综述。

关 键 词:乳腺癌  药物  靶向治疗  分子基础

The molecular basis of targeted therapy in breast cancer
LI Jing,HUANG Rui,LIU Xiujuan,LUO Ying,YANG Julun. The molecular basis of targeted therapy in breast cancer[J]. Chemistry of Life, 2014, 0(2): 306-311
Authors:LI Jing  HUANG Rui  LIU Xiujuan  LUO Ying  YANG Julun
Affiliation:1Medical Faculty of Kunming University of Science and Technology, Kunming 650500, China; 2Department of pathology, Kunming General Hospital of Chengdu Military Command, Kunming 650032, China; 3Kunming Medical University, Kunming 650031, China)
Abstract:In recent years, the research of targeted therapy in breast cancer has made significant progress. To treat the breast cancer, molecular targeted drugs have an effect on the molecular signaling transduction pathways of breast cancer cells, then specifically interfering with the abnormal links in the pathways, regulating the expression of related genes, inhibiting or killing the tumor cells. This paper presents a progress in molecular basis for targeted therapy in breast cancer.
Keywords:breast cancer  drugs  targeted therapy  molecular basis
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号